Cargando…
A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes
AIMS: Prediabetes has been proved as an important risk factor of both diabetes and cardiovascular disease (CVD). Previous studies have shown that both lifestyle intervention and pioglitazone may delay the development of diabetes in patients with prediabetes. However, no study has ever explored wheth...
Autores principales: | Luo, Yingying, Wang, Hongyuan, Zhou, Xianghai, Chang, Cuiqing, Chen, Wei, Guo, Xiaohui, Yang, Jinkui, Ji, Linong, Paul, Sanjoy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759441/ https://www.ncbi.nlm.nih.gov/pubmed/35036447 http://dx.doi.org/10.1155/2022/2971382 |
Ejemplares similares
-
Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes
por: Luo, Yingying, et al.
Publicado: (2017) -
Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes
por: Sevilla-Gonzalez, Magdalena del Rocio, et al.
Publicado: (2022) -
Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study
por: Huang, Xiuting, et al.
Publicado: (2020) -
Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
por: Cai, Xiaoling, et al.
Publicado: (2017) -
Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis
por: Jiang, Qiang, et al.
Publicado: (2022)